Stock SHUKRAPHAR6 SHUKRA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Shukra Pharmaceuticals Limited

Equities

SHUKRAPHAR6

INE551C01028

Market Closed - Bombay S.E.
Other stock markets
 03:30:57 28/06/2024 pm IST 		5-day change 1st Jan Change
111.4 INR -1.98% Intraday chart for Shukra Pharmaceuticals Limited -9.54% +260.08%
29/05 Shukra Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2023- 24 CI
29/05 Shukra Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shukra Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2023- 24
CI
Shukra Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Shukra Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Shukra Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Shukra Pharmaceuticals Limited Announces the Resignation of Jivansingh Gangasingh Negi as Independent Director
CI
Shukra Pharmaceuticals Limited Announces Board Changes
CI
Shukra Pharmaceuticals Limited Announces Directorate Resignations
CI
Shukra Pharmaceuticals Limited Announces Executive Changes
CI
Shukra Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Shukra Pharmaceuticals Limited Announces Resignation of Ashvin Trivedi as Non- Executive Director, Effective August 12, 2023
CI
Shukra Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2023
CI
Shukra Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
CI
Shukra Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2023
CI
Shukra Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Shukra Pharmaceuticals Limited Announces Board Changes
CI
Shukra Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Shukra Pharmaceuticals Limited Approves Final Dividend for the Financial Year 2021-22
CI
Shukra Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2021-22
CI
Shukra Pharmaceuticals to Raise Up to $2.4 Million from Equity Offering
MT
Shukra Pharmaceuticals Limited Appoints Rai Kavoorguthu Konark as Additional Independent Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SHUKRAPHAR6 Stock
  4. News Shukra Pharmaceuticals Limited